Parental body mass index and maternal gestational weight gain associations with offspring body composition in young women from the Nutritionists' Health Study

ABSTRACT Objective: Intrauterine environment can induce fetal metabolic programming that predisposes to adiposity-related chronic diseases in its lifespan. We examined the associations of parental nutritional status and gestational weight gain with offspring body composition in early adulthood. Materials and methods: This is cross-sectional analysis of female participants of the NutriHS who were submitted to questionnaires, clinical examinations and body composition assessed by DXA. Association of pre-conception parental BMI and maternal gestational weight gain (exposures) with body composition measurements (outcomes) were analyzed using multiple linear models adjusted for Directed Acyclic Graphs-based covariables (maternal and paternal educational level, maternal age, and tobacco, alcohol and/or drugs use). The sample included 124 women (median 28 (24-31) years) with a mean BMI of 25.4 ± 4.7 kg/m2. Results: No association between previous paternal BMI and offspring's body composition was detected. In the fully adjusted linear regression model, maternal BMI was associated with offspring's total lean mass (β = 0.66, p = 0.001), appendicular skeletal muscle mass index (ASMI) (β = 0.11, p = 0.003) and fat mass index (FMI) (β = 0.03, p = 0.039). Gestational weight gain was associated with increased offspring's BMI (OR 1.12 [95% CI 1.02-1.20], p = 0.01). The linear regression model adjusted for maternal age and maternal and paternal education levels showed associations of gestational weight gain with offspring's ASMI (β = 0.42, p = 0.046), FMI (β = 0.22, p = 0.005) and android-to-gynoid fat ratio (β = 0.09, p = 0.035). Conclusion: Our findings suggest that preconception maternal BMI could influence lean mass and general adiposity of young adult female offspring and that gestational weight gain could be useful for predicting centrally distributed adiposity.

Arginine and glutamine supplementation on transthyretin levels in severely burned patients: A systematic review.

OBJECTIVE: The aim of this study was to investigate the influence of supplementation with the immunomodulators arginine and glutamine on transthyretin levels in burn patients. METHODS: This systematic review followed the protocol proposed and registered in PROSPERO (CRD42021239526) and was carried out following the PRISMA checklist for systematic reviews. Forty-four studies were evaluated. Of the 44, we included 6 for complete analysis. RESULTS: In five of the six clinical trials, glutamine was the most used immunomodulator (0.5 g·kg·d-1 or 12-14 g/d), followed by arginine in three of the clinical trials (10-14 g/d in adults or 2% of total energy value in children). The findings of the studies were that the patients who received either of these supplements presented the following results: increased transthyretin, lymphoproliferative response, and serum glutamine values, as well as shorter stay in the intensive care unit, a significant reduction in C-reactive protein values, and a tendency toward a faster healing of the burns compared with the control groups. CONCLUSION: In view of the content in the present review, it is possible to affirm that the supplementation of immunomodulators in burn patients is an effective strategy for their treatment, and that the adequate nutritional offer may be a predictor of a favorable outcome. However, regarding the increase in transthyretin values, this finding needs to be considered with reservations as the values can be altered by the inflammatory activity, and not necessarily related to the use of a supplement.

Maternal and paternal obesity are associated with offspring obestatin levels in the Nutritionists' Health Study.

OBJECTIVES: The aim of this study was to examine whether paternal and maternal body mass indexes (BMIs) were independently associated with obestatin and visfatin levels in adult offspring. METHODS: This cross-sectional analysis included 124 women who participated in the Nutritionists' Health Study (NutriHS) at baseline. Early life events, anthropometry, dual-energy x-ray absorptiometry-determined body composition and blood sample were obtained. Associations of parental BMI with outcomes (obestatin and visfatin) were tested by multiple linear regression, using minimal sufficient adjustments recommended by Directed Acyclic Graph. Participants' mean BMI was 25 ± 5 kg/m2 and 74% were metabolically healthy. Median obestatin and visfatin levels were 56.4 pg/mL (42-72) and 17.7 ng/mL (14-21.8), respectively. Eleven percent of mothers and 39% of fathers were overweight/obese. RESULTS: Daughters born from overweight/obese mothers had higher BMI than those born from normal weight women (P = 0.003). In adjusted regression model, offspring obestatin levels were associated with maternal BMI (ß = -0.03; P = 0.045) and paternal BMI (ß = -0.02; P = 0.048) independently of maternal and paternal education, maternal age, and maternal use of tobacco, alcohol, and/or drugs. No association was detected with visfatin levels. CONCLUSION: Inverse associations of maternal and paternal BMIs with offspring obestatin concentrations in women could suggest a utility of this biomarker of energy regulation determined in early adulthood. Whether obestatin could be an indicator of protection against obesity-related disorders in the life course requires investigation in studies designed to test such hypothesis.

DEFINITION OF VITAMIN D DEFICIENCY IN SCHOOLCHILDREN: SYSTEMATIC REVIEW WITH META-ANALYSIS.

BACKGROUND: Vitamin D deficiency is being recognized as a pandemic due to the volume of people affected by the deficiency and the number of illnesses generated or stimulated by the deficiency. There is a lack of consensus in the literature on what is considered vitamin D deficiency [25(OH)D]. OBJECTIVE: This review brings together the most common levels of 25(OH)D found in healthy schoolchildren and what is considered deficient. METHODS: This systematic review was based on the literature accessed from the electronic databases: MEDLINE, EMBASE, LILACS, SCOPUS and WEB OF SCIENCE. The following descriptors were used in English, Portuguese and Spanish: "Vitamin D"; "Vitamin D deficiency"; "Nutritional Supplements" as well as all their synonyms. The meta-analysis was performed considering the random model. Inclusion criteria: healthy children aged 6 to 12 years, studies that had vitamin D levels, defined vitamin D deficiency. RESULTS: Of the 191 potentially eligible articles, only six articles were included, with 2618 students in total. The mean value of 25(OH)D was estimated at 18.11 ng/mL with 95% confidence interval. Among the articles found, three were considered deficiency levels below 20 ng/mL, one considered below 18 ng/mL, another below 15 ng/mL, and the latter below 11 ng/ mL. The prevalence of vitamin D deficiency among the articles was 48.6%, 7%, 98%, 64.63%, 19.5%, 28.4%, according to each classification used by the same. CONCLUSION: The most common definition in the literature of 25(OH)D deficiency in schoolchildren was at levels below 20 ng/mL. No side effects have been reported in studies that used fortification and/or vitamin D supplementation. Daily supplementation is more effective than seasonal supplementation. However, more studies are needed to define what can be considered as optimal levels of 25(OH)D in children.

Definição da deficiência de vitamina D em crianças em idade escolar: revisão sistemática com metanálise / Definition of vitamin d deficiency in schoolchildren: systematic review with meta-analysis

ABSTRACT BACKGROUND: Vitamin D deficiency is being recognized as a pandemic due to the volume of people affected by the deficiency and the number of illnesses generated or stimulated by the deficiency. There is a lack of consensus in the literature on what is considered vitamin D deficiency [25(OH)D]. OBJECTIVE: This review brings together the most common levels of 25(OH)D found in healthy schoolchildren and what is considered deficient. METHODS: This systematic review was based on the literature accessed from the electronic databases: MEDLINE, EMBASE, LILACS, SCOPUS and WEB OF SCIENCE. The following descriptors were used in English, Portuguese and Spanish: "Vitamin D"; "Vitamin D deficiency"; "Nutritional Supplements" as well as all their synonyms. The meta-analysis was performed considering the random model. Inclusion criteria: healthy children aged 6 to 12 years, studies that had vitamin D levels, defined vitamin D deficiency. RESULTS: Of the 191 potentially eligible articles, only six articles were included, with 2618 students in total. The mean value of 25(OH)D was estimated at 18.11 ng/mL with 95% confidence interval. Among the articles found, three were considered deficiency levels below 20 ng/mL, one considered below 18 ng/mL, another below 15 ng/mL, and the latter below 11 ng/ mL. The prevalence of vitamin D deficiency among the articles was 48.6%, 7%, 98%, 64.63%, 19.5%, 28.4%, according to each classification used by the same. CONCLUSION: The most common definition in the literature of 25(OH)D deficiency in schoolchildren was at levels below 20 ng/mL. No side effects have been reported in studies that used fortification and/or vitamin D supplementation. Daily supplementation is more effective than seasonal supplementation. However, more studies are needed to define what can be considered as optimal levels of 25(OH)D in children.

RESUMO CONTEXTO: A deficiência de vitamina D está sendo reconhecida como uma pandemia devido ao volume de pessoas afetadas pela deficiência e o número de doenças geradas ou estimuladas por tal deficiência. Há falta de consenso na literatura sobre o que é considerado deficiência de vitamina D [25(OH)D]. OBJETIVO: Esta revisão reúne os níveis mais comuns de 25(OH)D encontrados em escolares saudáveis e o que é considerado deficiência. MÉTODOS: Esta revisão sistemática foi baseada na literatura acessada a partir das bases de dados eletrônicas: MEDLINE, EMBASE, LILACS, SCOPUS e WEB OF SCIENCE. Foram utilizados os seguintes descritores em inglês, português e espanhol: "Vitamina D"; "Deficiência de vitamina D"; "Suplementos Nutricionais", bem como todos os seus sinônimos. A meta-análise foi realizada considerando o modelo aleatório. Critérios de inclusão: crianças saudáveis na faixa etária de 6 a 12 anos, estudos que tinham níveis de vitamina D, deficiência de vitamina D definida. RESULTADOS: Dos 191 artigos potencialmente elegíveis, apenas seis artigos foram incluídos, com 2618 escolares no total. O valor médio de 25(OH)D foi estimado em 18,11 ng/mL com 95% de intervalo de confiança. Dentre os artigos encontrados três consideraram deficiência níveis abaixo de 20 ng/mL, um considerou abaixo de 18 ng/mL, outro abaixo de 15 ng/mL, e o último abaixo de 11 ng/mL. A prevalência da deficiência de vitamina D entre os artigos foi de 48,6%, 7%, 98%, 64,63%, 19,5%, 28,4%, de acordo com cada classificação utilizada por eles. CONCLUSÃO: A definição mais comum na literatura de deficiência de 25(OH)D em escolares foi em níveis inferiores a 20 ng/mL. Nenhum efeito colateral foi relatado em estudos que usaram fortificação e/ou suplementação de vitamina D. A suplementação diária é mais eficaz do que a suplementação sazonal. No entanto, mais estudos são necessários para definir o que pode ser considerado como níveis ótimos de 25(OH)D em crianças.

Inflammatory process of patients receiving parenteral nutrition is not exclusively responsible for low selenium and glutathione peroxidase levels.

OBJECTIVE: The aim of this study was to verify if the selenium status of patients residing in locations with selenium-poor soil who receive parenteral nutrition (PN) without selenium supplementation is associated with the inflammatory process. METHODS: This was a prospective cohort study with hospitalized patients who started PN. The analyzed biochemical tests were plasma selenium, glutathione peroxidase (GPx), C-reactive protein, prealbumin, albumin, creatinine, lymphocytes, total cholesterol, high-density lipoprotein, and triglycerides. RESULTS: Seventy-seven patients with a mean age of 56.2 ± 15.7 y were studied. Most of them used PN as a result of clinical issues (70.1%) such as, gastric, renal, or hematologic neoplasia; gastrointestinal dysfunction; pancreatitis; sepsis; trauma without surgical needs; chylothorax; and fistula not related to surgical procedure. There were low levels of plasma selenium (98.7%) and GPx (60%) and elevated C-reactive protein (98.5%) in most cases. At the beginning of PN there was no correlation between selenium and laboratory tests (P > 0.05). At the second evaluation (seventh day of PN), there was a positive correlation of selenium levels with lymphocyte levels (r = 0.36; P = 0.04). After 2 wk of PN, there was a statistically significant correlation between selenium and GPx (r = 0.70; P = 0.02). CONCLUSIONS: Very low values of selenium and GPx from the beginning of PN were identified. The correlation of selenium levels with GPx in only 14 d of PN, regardless of inflammation, may reflect a critical selenium status, mainly because the correlation was verified after the acute phase. Therefore it is important to emphasize that supplementation should be started from the beginning of PN, especially in regions with selenium-deficient soil.

Selenium supplementation in pediatric patients using parenteral nutrition: Is it time to do something?

OBJECTIVE: To analyze the nutritional status of selenium and verify the effect of its supplementation in pediatric patients during 14 days of parenteral nutrition (PN). METHOD: This is a series of cases with patients followed for two weeks while using PN. Data collection was performed at the beginning (T0), in the 7th (T1) and 14th days of PN (T2). The supplemented group received 2 µg/kg/day of selenous acid. Weight and height were measured for nutritional status assessment. Tests requested: plasma selenium, albumin, pre-albumin, C-reactive protein (CRP), total cholesterol and HDL-cholesterol. RESULTS: Fourteen (14) patients with inflammatory process and with low or very low weight for their ages were evaluated. In both groups (with and without supplementation), all patients had low selenium levels. Median plasma selenium concentrations were 17.4 µg/L (T0), 23.0 µg/L (T1) and 20.7 µg/L (T2). Increase and reduction of selenium occurred both in patients with high CRP and in those presenting normalization of this parameter. CONCLUSION: Lower plasma selenium levels have been detected since the start of the research and supplementation (2 µg/kg/day of selenous acid) was not to enough to approach the reference values.

Selenium supplementation in pediatric patients using parenteral nutrition: Is it time to do something? / Suplementação de selênio nos pacientes pediátricos em uso de nutrição parenteral: é hora de fazer algo?

Summary Objective: To analyze the nutritional status of selenium and verify the effect of its supplementation in pediatric patients during 14 days of parenteral nutrition (PN). Method: This is a series of cases with patients followed for two weeks while using PN. Data collection was performed at the beginning (T0), in the 7th (T1) and 14th days of PN (T2). The supplemented group received 2 µg/kg/day of selenous acid. Weight and height were measured for nutritional status assessment. Tests requested: plasma selenium, albumin, pre-albumin, C-reactive protein (CRP), total cholesterol and HDL-cholesterol. Results: Fourteen (14) patients with inflammatory process and with low or very low weight for their ages were evaluated. In both groups (with and without supplementation), all patients had low selenium levels. Median plasma selenium concentrations were 17.4 µg/L (T0), 23.0 µg/L (T1) and 20.7 µg/L (T2). Increase and reduction of selenium occurred both in patients with high CRP and in those presenting normalization of this parameter. Conclusion: Lower plasma selenium levels have been detected since the start of the research and supplementation (2 µg/kg/day of selenous acid) was not to enough to approach the reference values.

Resumo Objetivo: Analisar o estado nutricional relativo ao selênio e verificar o efeito da suplementação desse mineral em pacientes pediátricos durante 14 dias de nutrição parenteral (NP). Método: Trata-se de estudo prospectivo de uma série de casos de pacientes acompanhados durante duas semanas de uso de NP. A coleta de dados foi realizada no início (T0), no 7º (T1) e no 14º dia de NP (T2). Após randomização, o grupo suplementado recebeu 2 µg/kg/dia de ácido selenioso. Peso e altura foram aferidos para avaliação do estado nutricional. Exames coletados: selênio plasmático, albumina, pré-albumina, proteína C-reativa (PCR), colesterol total e HDL-colesterol. Resultados: Foram avaliados 14 pacientes com processo inflamatório em curso e com baixo ou muito baixo peso para a idade. Os pacientes (grupo suplementado e não suplementado) tinham baixas concentrações de selênio. A mediana dos valores de selênio plasmático foi de 17,4 µg/L (T0), 23,0 µg/L (T1) e 20,7 µg/L (T2). Aumento e redução de selênio ocorreram tanto nos pacientes com PCR elevada quanto naqueles que apresentaram normalização desse parâmetro. Conclusão: Os níveis de selênio detectados foram muito baixos e a suplementação (2 µg/kg/dia de ácido selenioso) não foi suficiente para normalização dos níveis plasmáticos.

Influence of selenium supplementation on patients with inflammation: A pilot double blind randomized study.

OBJECTIVE: The aim of the study was to analyze the effect of selenium supplementation on patients with inflammation receiving PN. METHODS: This double-blind randomized study included 20 hospitalized patients experiencing an inflammatory process while being fed by PN, who were monitored in three stages: first 72 h (0), day 7 (1), and day 14 (2) of PN. The supplemented patients group (G+S) received 60 µg/d (0.75 µmol) of selenium as selenious acid which was added to the PN bag. The nonsupplemented group (G-S) did not receive selenium. The concentration range of 84 to 100 µg/L (1.07-1.27 µmol/L) was used as a reference of plasma selenium. RESULTS: The study included 20 patients (8 G+S and 12 G-S) mainly diagnosed with cancer and/or sepsis. Most of them were hospitalized in the intensive care unit and were receiving PN for clinical reasons. Plasma selenium was greater in the G+S than in the G-S (P = 0.05) in two stages (0 and 1). Since the start of assessment, C-reactive protein (CRP) levels were elevated; however, there was no statistical difference in CRP values between groups (P > 0.05). There was no significant change of glutathione peroxidase over time or between groups (P > 0.05). CONCLUSION: The selenium concentration was greater in the G+S than in the G-S, acting independently from CRP behavior. However, supplementation was not enough to reach the reference values.

Is plasma selenium correlated to transthyretin levels in critically ill patients? / ¿Se correlacionan los niveles plasmáticos de selenio con los de prealbúmina en los pacientes críticos?

Background: Selenium is an essential trace element, but critically ill patients using total parenteral nutrition (PN) do not receive selenium because this mineral is not commonly offered. Threfore, the evaluation of plasma selenium levels is very important for treating or preventing this deficiency. Recent studies have shown that transthyretin may reflect the selenium intake and could be considered a biomarker. However, this issue is still little explored in the literature. Objective: This study aims to investigate the correlation of transthyretin with the plasma selenium of critically ill patients receiving PN. Method: This was a prospective cohort study with 44 patients using PN without selenium. Blood samples were carried out in 3 stages: initial, 7th and 14th day of PN. In order to evaluate the clinical condition and the inflammatory process, albumin, C-reactive protein (CRP), transthyretin, creatinine and HDL cholesterol levels were observed. To assess the selenium status, plasma selenium and glutathione peroxidase (GPx) in whole blood were measured. Descriptive analyses were performed and the ANOVA, Mann-Whitney and Spearman’s coefficient tests were conducted; we assumed a significance level of 5%. Results: A positive correlation of selenium with the GPx levels (r = 0.46; p = 0.03) was identified. During two weeks, there was a positive correlation of transthyretin with plasma selenium (r = 0.71; p = 0.05) regardless of the CRP values. Conclusion: Transthyretin may have reflected plasma selenium, mainly because the correlation was verified after the acute phase (AU)

Introducción: el selenio es un oligoelemento esencial. Sin embargo, los pacientes críticos con nutrición parenteral (NP) no reciben selenio de forma habitual. La evaluación de los niveles plasmáticos de selenio se vuelve imprescindible en este contexto, para prevenir las deficiencias. Algunos estudios recientes han demostrado que los niveles de prealbúmina pueden reflejar los aportes de selenio y servir como biomarcador del estado de selenio. Esta posibilidad se ha evaluado de una forma insuficiente. Objetivo: investigar la correlación entre los niveles plasmáticos de selenio y de prealbúmina en el paciente crítico. Método: estudio prospectivo de una cohorte de 44 pacientes que recibían NP sin selenio. Se extrajeron muestras de sangre en el momento del inicio y a los 7 y 14 días de NP. Para evaluar la situación clínica y el proceso inflamatorio, se midieron también los niveles de albúmina, proteína C reactiva (PCR), prealbúmina, creatinina y colesterol HDL. Para evaluar el estado de selenio, se midieron los niveles de selenio y de glutation peroxidasa (GPx) en sangre completa. Se realizó un análisis descriptivo así como los siguientes estudios estadísticos: ANOVA, Mann-Whitney y coeficiente de correlación de Spearman, asumiendo un nivel de significación estadística del 5%. Resultados: se encontró una correlación positiva con los niveles de GPX (r = 0,46; p = 0,03). Durante las dos semanas de estudio, hubo correlación entre los niveles plasmático de selenio y de prealbúmina (r = 0,71; p = 0,05), con independencia de los niveles de PCR. Conclusión: la prealbúmina puede reflejar los niveles plasmáticos de selenio, al demostrar una buena correlación tras la fase aguda de la agresión (AU)

Protein needs of critically ill patients receiving parenteral nutrition / Las necesidades proteícas de pacientes en estado crítico que reciben nutrición parenteral

Background: assess whether the current protein intake recommendations may improve the biochemical parameters of critical patients receiving parenteral nutrition. Methods: longitudinal study with three evaluations made (during the first 72 hours, on the 7th and the 14th days of PN). The following tests were applied: albumin, C-reactive protein, prealbumin, total cholesterol, HDL, triglycerides, lymphocytes, and glutathione peroxidase. The severity was determined by SOFA. The statistical analysis included the Spearman and Mann-Whitney tests, as well as ANOVA (analysis of variance). Results: among the 53 patients evaluated, 20 (37.74%) died. The mean calorie was 24.68±9.78 kcal/kg (beginning of PN), 26.49±8.89 kcal/kg (3rd to 7th days of PN), and 30.9±12.19 kcal/kg (7th to 14th days of PN). The mean protein was 1.19±0.44 g/kcal/kg (first 72 hours of PN), 1.29±0.44 g/kcal/kg (3rd to 7th days of PN) and 1.49±0.69 g/kcal/kg (7th to 14th days of PN). Prealbumin, albumin, total cholesterol and HDL were below the reference values, while the CRP levels were high. Throughout the three evaluation times, there was no a significant improvement on the levels of laboratory examinations. A strong and negative correlation was found between SOFA and prealbumin (r=-0.64, p=0.05). Conclusions: the protein offer, according to the traditional recommendations, was not enough to improve the biochemical parameters of critical patients undergoing parenteral nutrition (AU)

Introducción: evaluar si las recomendaciones de ingesta de proteínas actuales pueden mejorar los parámetros bioquímicos de los pacientes críticos que reciben nutrición parenteral. Métodos: estudio longitudinal con tres evaluaciones realizadas (durante las primeras 72 horas, en el séptimo y los días decimocuarto de nutrición parenteral). Se aplicaron las siguientes pruebas: albúmina, proteína C reactiva, prealbúmina, colesterol total, HDL, triglicé- ridos, linfocitos y glutatión peroxidasa. La gravedad se determinó por SOFA. El análisis estadístico incluyó las pruebas de Spearman y Mann-Whitney, así como ANOVA (análisis de varianza). Resultados: de los 53 pacientes evaluados, 20 (37,74%) fallecieron. La caloría media fue de 24,68±9,78 kcal/kg (comienzo de PN), 26,49±8,89 kcal/kg (tercero-séptimo días de PN), y 30,9±12,19 kcal/kg (séptimo-décimo cuarto días de PN). La proteína media fue de 1,19±0,44 g/ kcal/kg (primeras 72 horas de PN), 1,29±0,44 g/kcal/kg (tercero-séptimo días de PN) y 1,49±0,69 g/kcal/kg (séptimo-decimocuarto días de PN). La prealbúmina, la albú- mina, el colesterol total y la HDL estaban por debajo de los valores de referencia, mientras que los niveles de PCR eran altos. A lo largo de los tres tiempos de evaluación, no hay una mejora significativa en los niveles de los exá- menes de laboratorio. Una correlación fuerte y negativa entre SOFA y prealbúmina (r=-0,64, p=0,05). Conclusiones: la oferta de proteínas, de acuerdo con las recomendaciones tradicionales, no fue suficiente para mejorar los parámetros bioquímicos de los pacientes crí- ticos sometidos a nutrición parenteral (AU)

[Should pediatric parenteral nutrition be individualized?]. / Deve-se individualizar a nutrição parenteral pediátrica?

INTRODUCTION: Parenteral nutrition (PN) formulations are commonly individualized, since their standardization seem inadequate for the pediatric population. This study aimed to evaluate the nutritional state and the reasons for PN individualization in pediatric patients using PN hospitalized in a tertiary hospital in Campinas, São Paulo. METHODS: This longitudinal study comprised patients using PN followed by up to 67 days. Nutritional status was classified according to the criteria established by the World Health Organization (WHO) (2006) and WHO (2007). The levels of the following elements on blood were analyzed: sodium, potassium, ionized calcium, chloride, magnesium, inorganic phosphorus and triglycerides (TGL). Among the criteria for individualization, were considered undeniable: significant reduction in blood levels of potassium (<3 mEq/L), sodium (<125 mEq/)L, magnesium (<1 mEq/L), phosphorus (<1.5 mEq/L), ionic calcium (<1 mmol) and chloride (<90 mEq/L) or any value above the references. RESULTS: Twelve pediatric patients aged 1 month to 15 years were studied (49 individualizations). Most patients were classified as malnourished. It was observed that 74/254 (29.2%) of examinations demanded individualized PN by indubitable reasons. CONCLUSION: The nutritional state of patients was considered critical in most cases. Thus, the individualization performed in the beginning of PN for energy protein adequacy was indispensable. In addition, the individualized PN was indispensable in at least 29.2% of PN for correction of alterations found in biochemical parameters.

Should pediatric parenteral nutrition be individualized? / Deve-se individualizar a nutrição parenteral pediátrica?

INTRODUCTION: Parenteral nutrition (PN) formulations are commonly individualized, since their standardization appears inadequate for the pediatric population. This study aimed to evaluate the nutritional state and the reasons for PN individualization in pediatric patients using PN, hospitalized in a tertiary hospital in Campinas, São Paulo. METHODS: This longitudinal study comprised patients using PN followed by up to 67 days. Nutritional status was classified according to the criteria established by the World Health Organization (WHO) (2006) and WHO (2007). The levels of the following elements in blood were analyzed: sodium, potassium, ionized calcium, chloride, magnesium, inorganic phosphorus, and triglycerides (TGL). Among the criteria for individualization, the following were considered undeniable: significant reduction in blood levels of potassium (<3mEq/L), sodium (<125mEq/L), magnesium (<1mEq/L), phosphorus (<1.5mEq/L), ionic calcium (<1mmol), and chloride (<90mEq/L), or any value above the references. RESULTS: Twelve pediatric patients aged 1 month to 15 years were studied (49 individualizations). Most patients were classified as malnourished. It was observed that 74/254 (29.2%) of examinations demanded individualized PN for indubitable reasons. CONCLUSION: The nutritional state of patients was considered critical in most cases. Thus, the individualization performed in the beginning of PN for energy protein adequacy was indispensable. In addition, the individualized PN was indispensable in at least 29.2% of PN for correction of alterations found in biochemical parameters...

INTRODUÇÃO: As formulações da nutrição parenteral (NP) são comumente individualizadas, visto que a padronização destas parece inadequada para a população pediátrica. O objetivo do estudo foi avaliar o estado nutricional e os motivos para individualização da NP dos pacientes pediátricos em uso de NP internados em um hospital terciário de Campinas-SP. MÉTODOS: Estudo longitudinal conduzido com pacientes acompanhados por até 67 dias de uso de NP. Para a classificação do estado nutricional, foram utilizados os critérios propostos pela World Health Organization (WHO) (2006) e WHO (2007). As dosagens sanguíneas analisadas foram: sódio, potássio, cálcio iônico, cloreto, magnésio, fósforo inorgânico e triglicerídeo (TGL). Foram considerados motivos indubitáveis para individualização da NP quando esses elementos apresentavam redução expressiva dos níveis sanguíneos (potássio <3 mEq/L; sódio <125 mEq/L; magnésio <1 mEq/L; fósforo <1,5 mEq/L; cálcio iônico <1 mmol/L; cloreto <90 mEq/L) ou qualquer valor superior aos de referência. RESULTADOS: Foram estudados 12 pacientes (49 individualizações) com idade de 1 mês a 15 anos. A maioria dos pacientes foi classificada como desnutrida. Observou-se que 74/254 (29,2%) dos exames demandaram NP individualizada por motivos indubitáveis. CONCLUSÃO: O estado nutricional dos pacientes foi considerado crítico, na maioria dos casos. Desta forma, a individualização realizada no início da NP para a adequação energética proteica foi essencial. Além disto, a NP individualizada foi indispensável em, no mínimo, 29,2% das NP, para correção das alterações encontradas nos exames...